ENTPD1 and neoplasm: Importantly, after co-incubating these tumor cells with POM-1, the CD39 inhibitor, tumor-induced inhibition of CD4+ and CD8+ T cell proliferation was alleviated and CTL- or NK cell-mediated cytotoxicity increased.